Replies to post #171369 on Avid Bioservices Inc (CDMO)

[thealias2002]

Are his research rights 'owned' by a biotech or pharma ala Thorpe/PPHM/UTSW?

Curious

[biopharm]

Dana Farber has Troy Luster working on vaccines...who used to work in the late Dr. Thorpes lab and always wondered why he left.

These are one of the possible collaborations that I never posted before-- but since Peregrine now releases they have "24" at the miniumum in progress and pre-clinical Bruce Friemark has been on the PAV list of Troy Luster for many months now, along with Dr. Brekken and other UTSWM profiles... and still would be interesting to find out why Troy leaves such historic potential/breakthroughs soon to hopefully be announced : )

-------------------------------------------------------

page 16/17 ... drug molecules : "not disclosed"

http://evotec.sissy.bgcc.at/uploads/media_library/10/2014-09_Evotec_Company_presentation_September_e.pdf

--------------------------------------------------------

Edison Investment Research ... owns EvoTech, where Troy Luster working with now out of Dana Farber and they have listed here a few drugs not being disclosed:

pg.4
Target Sx ... Target Kx.. and one undisclosed: -- no info on all three

pg 5.
Not disclosed Phase I Oncology/
Boehringer Ingelheim
Boehringer Ingelheim initiated a Phase I trial with an oncology compound in September 2013, triggering a €2m payment to Evotec. No further details have been disclosed

Sept 12, 2014

here is the cached link:
http://webcache.googleusercontent.com/search?q=cache:hZD19CDpdR4J:www.edisoninvestmentresearch.com/%3FACT%3D18%26ID%3D12697+&cd=1&hl=en&ct=clnk&gl=us

or its the 1st link, pdf file... just out today Sept 12, 2014

https://www.google.com/?gws_rd=ssl#q=evotec+belfer+institute&tbs=qdr:m